-
1
-
-
0034764239
-
Prospective multicenter clinical evaluation of Amplicor and Cobas Amplicor hepatitis C virus tests
-
Nolte F.S., Fried M.W., Shiffman M.L., Ferreira-Gonzalez A., Garrett C.T., Schiff E.R., et al. Prospective multicenter clinical evaluation of Amplicor and Cobas Amplicor hepatitis C virus tests. J Clin Microbiol 39 (2001) 4005-4012
-
(2001)
J Clin Microbiol
, vol.39
, pp. 4005-4012
-
-
Nolte, F.S.1
Fried, M.W.2
Shiffman, M.L.3
Ferreira-Gonzalez, A.4
Garrett, C.T.5
Schiff, E.R.6
-
2
-
-
0034461502
-
Improved version 2.0 qualitative and quantitative Amplicor reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics
-
Lee S.C., Antony A., Lee N., Leibow J., Yang J.Q., Soviero S., et al. Improved version 2.0 qualitative and quantitative Amplicor reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol 38 (2000) 4171-4179
-
(2000)
J Clin Microbiol
, vol.38
, pp. 4171-4179
-
-
Lee, S.C.1
Antony, A.2
Lee, N.3
Leibow, J.4
Yang, J.Q.5
Soviero, S.6
-
3
-
-
0034082547
-
Performance of the Cobas Amplicor HCV Monitor test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination
-
Gerken G., Rothaar T., Rumi M.G., Soffredini R., Trippler M., Blunk M.J., et al. Performance of the Cobas Amplicor HCV Monitor test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination. J Clin Microbiol 38 (2000) 2210-2214
-
(2000)
J Clin Microbiol
, vol.38
, pp. 2210-2214
-
-
Gerken, G.1
Rothaar, T.2
Rumi, M.G.3
Soffredini, R.4
Trippler, M.5
Blunk, M.J.6
-
4
-
-
0036175978
-
Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay
-
Ross R.S., Viazov S., Sarr S., Hoffmann S., Kramer A., and Roggendorf M. Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay. J Virol Methods 101 (2002) 159-168
-
(2002)
J Virol Methods
, vol.101
, pp. 159-168
-
-
Ross, R.S.1
Viazov, S.2
Sarr, S.3
Hoffmann, S.4
Kramer, A.5
Roggendorf, M.6
-
5
-
-
0033802570
-
Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays
-
Sarrazin C., Teuber G., Kokka R., Rabenau H., and Zeuzem S. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology 32 (2000) 818-823
-
(2000)
Hepatology
, vol.32
, pp. 818-823
-
-
Sarrazin, C.1
Teuber, G.2
Kokka, R.3
Rabenau, H.4
Zeuzem, S.5
-
6
-
-
10744220199
-
Performance attributes of the LCx HCV RNA quantitative assay
-
Leckie G., Schneider G., Abravaya K., Hoenle R., Johanson J., Lampinen J., et al. Performance attributes of the LCx HCV RNA quantitative assay. J Virol Methods 115 (2004) 207-215
-
(2004)
J Virol Methods
, vol.115
, pp. 207-215
-
-
Leckie, G.1
Schneider, G.2
Abravaya, K.3
Hoenle, R.4
Johanson, J.5
Lampinen, J.6
-
7
-
-
34547395999
-
Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method
-
Chevaliez S., Bouvier-Alias M., Brillet R., and Pawlotsky J.M. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology 46 (2007) 22-31
-
(2007)
Hepatology
, vol.46
, pp. 22-31
-
-
Chevaliez, S.1
Bouvier-Alias, M.2
Brillet, R.3
Pawlotsky, J.M.4
-
8
-
-
66749184153
-
Performance of the Abbott m2000SP/m2000RT Real-time polymerase chain reaction assay for hepatitis C virus RNA quantification
-
Chevaliez S., Bouvier-Alias M., and Pawlotsky J.M. Performance of the Abbott m2000SP/m2000RT Real-time polymerase chain reaction assay for hepatitis C virus RNA quantification. J Clin Microbiol 47 (2009) 1726-1732
-
(2009)
J Clin Microbiol
, vol.47
, pp. 1726-1732
-
-
Chevaliez, S.1
Bouvier-Alias, M.2
Pawlotsky, J.M.3
-
9
-
-
33846063686
-
Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA
-
Michelin B.D., Muller Z., Stelzl E., Marth E., and Kessler H.H. Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA. J Clin Virol 38 (2007) 96-100
-
(2007)
J Clin Virol
, vol.38
, pp. 96-100
-
-
Michelin, B.D.1
Muller, Z.2
Stelzl, E.3
Marth, E.4
Kessler, H.H.5
-
10
-
-
50849137806
-
Evaluation of an automated, highly sensitive, real-time PCR-based assay (Cobas Ampliprep/Cobas TaqMan) for quantification of HCV RNA
-
Sarrazin C., Dragan A., Gartner B.C., Forman M.S., Traver S., Zeuzem S., et al. Evaluation of an automated, highly sensitive, real-time PCR-based assay (Cobas Ampliprep/Cobas TaqMan) for quantification of HCV RNA. J Clin Virol 43 (2008) 162-168
-
(2008)
J Clin Virol
, vol.43
, pp. 162-168
-
-
Sarrazin, C.1
Dragan, A.2
Gartner, B.C.3
Forman, M.S.4
Traver, S.5
Zeuzem, S.6
-
11
-
-
33644889424
-
Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5
-
Sarrazin C., Gärtner B., Sizmann D., Babiel R., Mihm U., Hofmann W.P., et al. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. J Clin Microbiol 44 (2006) 729-737
-
(2006)
J Clin Microbiol
, vol.44
, pp. 729-737
-
-
Sarrazin, C.1
Gärtner, B.2
Sizmann, D.3
Babiel, R.4
Mihm, U.5
Hofmann, W.P.6
-
12
-
-
57349116917
-
Differences between two real-time PCR based assays (RealTime HCV, Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for HCV RNA detection and quantification
-
Vermehren J., Kau A., Gartner B.C., Gobel R., Zeuzem S., and Sarrazin C. Differences between two real-time PCR based assays (RealTime HCV, Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for HCV RNA detection and quantification. J Clin Microbiol 46 (2008) 3880-3891
-
(2008)
J Clin Microbiol
, vol.46
, pp. 3880-3891
-
-
Vermehren, J.1
Kau, A.2
Gartner, B.C.3
Gobel, R.4
Zeuzem, S.5
Sarrazin, C.6
-
13
-
-
33947133809
-
Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the Cobas AmpliPrep/Cobas TaqMan system
-
Sizmann D., Boeck C., Boelter J., Fischer D., Miethke M., Nicolaus S., et al. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the Cobas AmpliPrep/Cobas TaqMan system. J Clin Virol 38 (2007) 326-333
-
(2007)
J Clin Virol
, vol.38
, pp. 326-333
-
-
Sizmann, D.1
Boeck, C.2
Boelter, J.3
Fischer, D.4
Miethke, M.5
Nicolaus, S.6
-
14
-
-
20544443172
-
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3
-
Mangia A., Santoro R., Minerva N., Ricci G.L., Carretta V., Persico M., et al. Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. N Engl J Med 352 (2005) 2609-2617
-
(2005)
N Engl J Med
, vol.352
, pp. 2609-2617
-
-
Mangia, A.1
Santoro, R.2
Minerva, N.3
Ricci, G.L.4
Carretta, V.5
Persico, M.6
-
15
-
-
33646590308
-
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy
-
Jensen D.M., Morgan T.R., Marcellin P., Pockros P.J., Reddy K.R., Hadziyannis S.J., et al. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology 43 (2006) 954-960
-
(2006)
Hepatology
, vol.43
, pp. 954-960
-
-
Jensen, D.M.1
Morgan, T.R.2
Marcellin, P.3
Pockros, P.J.4
Reddy, K.R.5
Hadziyannis, S.J.6
-
16
-
-
28844451934
-
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia
-
Zeuzem S., Buti M., Ferenci P., Sperl J., Horsmans Y., Cianciara J., et al. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. J Hepatol 44 (2006) 97-103
-
(2006)
J Hepatol
, vol.44
, pp. 97-103
-
-
Zeuzem, S.1
Buti, M.2
Ferenci, P.3
Sperl, J.4
Horsmans, Y.5
Cianciara, J.6
-
17
-
-
34147207791
-
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
-
Yu M.L., Dai C.Y., Huang J.F., Hou N.J., Lee L.P., Hsieh M.Y., et al. A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C. Gut 56 (2007) 553-559
-
(2007)
Gut
, vol.56
, pp. 553-559
-
-
Yu, M.L.1
Dai, C.Y.2
Huang, J.F.3
Hou, N.J.4
Lee, L.P.5
Hsieh, M.Y.6
-
18
-
-
38649090068
-
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
-
Dalgard O., Bjoro K., Ring-Larsen H., Bjornsson E., Holberg-Petersen M., Skovlund E., et al. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response. Hepatology 47 (2008) 35-42
-
(2008)
Hepatology
, vol.47
, pp. 35-42
-
-
Dalgard, O.1
Bjoro, K.2
Ring-Larsen, H.3
Bjornsson, E.4
Holberg-Petersen, M.5
Skovlund, E.6
-
19
-
-
48749099989
-
Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response
-
Ferenci P., Laferl H., Scherzer T.M., Gschwantler M., Maieron A., Brunner H., et al. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology 135 (2008) 451-458
-
(2008)
Gastroenterology
, vol.135
, pp. 451-458
-
-
Ferenci, P.1
Laferl, H.2
Scherzer, T.M.3
Gschwantler, M.4
Maieron, A.5
Brunner, H.6
-
20
-
-
38649090347
-
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial
-
Mangia A., Minerva N., Bacca D., Cozzolongo R., Ricci G.L., Carretta V., et al. Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial. Hepatology 47 (2008) 43-50
-
(2008)
Hepatology
, vol.47
, pp. 43-50
-
-
Mangia, A.1
Minerva, N.2
Bacca, D.3
Cozzolongo, R.4
Ricci, G.L.5
Carretta, V.6
-
21
-
-
46249114151
-
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial
-
Yu M.L., Dai C.Y., Huang J.F., Chiu C.F., Yang Y.H., Hou N.J., et al. Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial. Hepatology 47 (2008) 1884-1893
-
(2008)
Hepatology
, vol.47
, pp. 1884-1893
-
-
Yu, M.L.1
Dai, C.Y.2
Huang, J.F.3
Chiu, C.F.4
Yang, Y.H.5
Hou, N.J.6
-
22
-
-
34447318385
-
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
-
Shiffman M.L., Suter F., Bacon B.R., Nelson D., Harley H., Sola R., et al. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl J Med 357 (2007) 124-134
-
(2007)
N Engl J Med
, vol.357
, pp. 124-134
-
-
Shiffman, M.L.1
Suter, F.2
Bacon, B.R.3
Nelson, D.4
Harley, H.5
Sola, R.6
-
23
-
-
68949183162
-
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients
-
Berg T., Weich V., Teuber G., Klinker H., Moller B., Rasenack J., et al. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients. Hepatology 50 (2009) 369-377
-
(2009)
Hepatology
, vol.50
, pp. 369-377
-
-
Berg, T.1
Weich, V.2
Teuber, G.3
Klinker, H.4
Moller, B.5
Rasenack, J.6
-
24
-
-
77951432006
-
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin
-
Epub ahead of print
-
Diago M, Shiffman ML, Bronowicki JP, Zeuzem S, Rodriguez-Torres M, Pappas SC, et al. Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin. Hepatology 2010 [Epub ahead of print].
-
Hepatology
, pp. 2010
-
-
Diago, M.1
Shiffman, M.L.2
Bronowicki, J.P.3
Zeuzem, S.4
Rodriguez-Torres, M.5
Pappas, S.C.6
-
25
-
-
33645992473
-
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
-
Berg T., von Wagner M., Nasser S., Sarrazin C., Heintges T., Gerlach T., et al. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 130 (2006) 1086-1097
-
(2006)
Gastroenterology
, vol.130
, pp. 1086-1097
-
-
Berg, T.1
von Wagner, M.2
Nasser, S.3
Sarrazin, C.4
Heintges, T.5
Gerlach, T.6
-
26
-
-
33746564989
-
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment
-
Sanchez-Tapias J.M., Diago M., Escartin P., Enriquez J., Romero-Gomez M., Barcena R., et al. Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment. Gastroenterology 131 (2006) 451-460
-
(2006)
Gastroenterology
, vol.131
, pp. 451-460
-
-
Sanchez-Tapias, J.M.1
Diago, M.2
Escartin, P.3
Enriquez, J.4
Romero-Gomez, M.5
Barcena, R.6
-
27
-
-
37749051824
-
Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow responders
-
Pearlman B.L., Ehleben C., and Saifee S. Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow responders. Hepatology 46 (2007) 1688-1694
-
(2007)
Hepatology
, vol.46
, pp. 1688-1694
-
-
Pearlman, B.L.1
Ehleben, C.2
Saifee, S.3
-
28
-
-
60749103034
-
A randomized study of extended treatment with peginterferon alpha-2b plus ribavirin based on time to HCV RNA negative-status in patients with genotype 1b chronic hepatitis C
-
Ide T., Hino T., Ogata K., Miyajima I., Kuwahara R., Kuhara K., et al. A randomized study of extended treatment with peginterferon alpha-2b plus ribavirin based on time to HCV RNA negative-status in patients with genotype 1b chronic hepatitis C. Am J Gastroenterol 104 (2009) 70-75
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 70-75
-
-
Ide, T.1
Hino, T.2
Ogata, K.3
Miyajima, I.4
Kuwahara, R.5
Kuhara, K.6
-
29
-
-
1542378867
-
Peginterferon-alfa2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose
-
Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., et al. Peginterferon-alfa2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose. Ann Intern Med 140 (2004) 346-355
-
(2004)
Ann Intern Med
, vol.140
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette Jr., H.2
Morgan, T.R.3
Balan, V.4
Diago, M.5
Marcellin, P.6
-
30
-
-
0041822106
-
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
-
Davis G.L., Wong J.B., McHutchison J.G., Manns M.P., Harvey J., and Albrecht J. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 38 (2003) 645-652
-
(2003)
Hepatology
, vol.38
, pp. 645-652
-
-
Davis, G.L.1
Wong, J.B.2
McHutchison, J.G.3
Manns, M.P.4
Harvey, J.5
Albrecht, J.6
-
31
-
-
0037371144
-
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy
-
Berg T., Sarrazin C., Herrmann E., Hinrichsen H., Gerlach T., Zachoval R., et al. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology 37 (2003) 600-609
-
(2003)
Hepatology
, vol.37
, pp. 600-609
-
-
Berg, T.1
Sarrazin, C.2
Herrmann, E.3
Hinrichsen, H.4
Gerlach, T.5
Zachoval, R.6
-
32
-
-
41849102023
-
Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods
-
Carlsson T., Quist A., and Weiland O. Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods. J Med Virol 80 (2008) 803-807
-
(2008)
J Med Virol
, vol.80
, pp. 803-807
-
-
Carlsson, T.1
Quist, A.2
Weiland, O.3
-
33
-
-
0035020530
-
Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples
-
Kessler H.H., Stelzl E., Raggam R.B., Haas J., Kirchmeir F., Hegenbarth K., et al. Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples. J Clin Microbiol 39 (2001) 1788-1790
-
(2001)
J Clin Microbiol
, vol.39
, pp. 1788-1790
-
-
Kessler, H.H.1
Stelzl, E.2
Raggam, R.B.3
Haas, J.4
Kirchmeir, F.5
Hegenbarth, K.6
|